IPX203 (ER CD-LD) super-responders: Description of a patient subpopulation reaping extra benefits in dose-response when converting from IR CD-LD
Objective: To generate quantitative data helping dose optimization when converting Parkinson’s disease (PD) patients from IR CD-LD to IPX203. Background: IPX203 is the first extended-release…Theta burst transcranial ultrasound stimulation of internal globus pallidus and motor cortex in Parkinson’s disease
Objective: To compared the effects of theta burst transcranial ultrasound stimulation (tbTUS) applied to M1, the GPi, and simultaneous M1 and GPi stimulation to investigate…Retro walking: A Potential Indicator of Physical Frailty in Parkinson’s Disease.
Objective: To examine the associations between retro walking and frailty parameters such as low grip strength, exhaustion, low physical activity and weight loss and compare…Investigation of cortex – basal ganglia pathways with cortical stimulation and subthalamic evoked responses in patients with Parkinson’s disease
Objective: To investigate the electrophysiological interplay between the human cortex and the subthalamic nucleus (STN) by comparing STN responses to direct cortical electrical stimulation and…Diagnostic Work Up when Suspecting Early Onset Parkinson Disease (EOPD) Recommendations from the MDS EOPD Study Group
Objective: Objective: To establish recommendations regarding which investigations are needed for the diagnosis of Early onset Parkinson’s disease (EOPD) Background: Background: EOPD has been defined…Advancing the Quality of Life of Parkinson’s Disease (PD) Patients in Ethiopia: The Impact of Self-Management and Coping Skills Training Programs on Patients in a Resource Constrained Settings
Objective: Evaluating the effectiveness of training in self-management and coping skills for patients with PD Background: The Parkinson’s Patients Support Organization Ethiopia (PPSO-E) implemented a…G-Can, the GBA1 Canada Initiative
Objective: G-Can, the GBA1 Canada Initiative, is an open-science platform which aims to advance GBA1 research and develop treatments for GBA1 mutation-related Parkinson's disease (PD).…Screening for Neuronal Synuclein Disease (NSD) using cerebrospinal fluid (CSF) in the Parkinson Progression Marker Initiative (PPMI)
Objective: To utilize a centralized screening paradigm for early stage NSD based on sequential olfactory dysfunction (measured by University of Pennsylvania Smell Identification test (UPSIT))…Exploring Clinical and Neurophysiologic Predictors of Adaptive Deep Brain Stimulation Response in Parkinson’s disease
Objective: To evaluate clinical and neurophysiologic characteristics that may predict a positive clinical response to adaptive deep brain stimulation (aDBS) in patients previously stable on…Tavapadon Is Not Associated With Increased Daytime Sleepiness in People With Parkinson’s Disease
Objective: To evaluate daytime sleepiness in people with Parkinson’s disease (PD) treated with tavapadon as monotherapy (TEMPO-1; NCT04201093) or adjunctive to levodopa (TEMPO-3; NCT04542499). Background:…
- « Previous Page
- 1
- …
- 71
- 72
- 73
- 74
- 75
- …
- 181
- Next Page »